Saturday, November 7, 2026

Diageo: First Quarter on Dave’s Plan Wasn’t Too Drastic

Diageo’s first quarter under CEO Dave Lewis showed modest price changes and regional growth outside North America, supporting a turnaround without drastic further cuts.

DEO $55B

Librarian Capital's Research Library 4h ago 1 click

5h ago TSEM $15B

Tower Semiconductor Update, Part Two

CV's Substack 1 click

6h ago PRM $4.8B

Perimeter Group: 3Q26 Business Recap

Speedwell Memos 1 click

From X

@BarbarianCap 1h ago

Barbarian Capital on X

random $GLD and $LQD (IG corp) are both in a 24.88% drawdown

@natstewart5 2h ago

Nat Stewart on X

@cannibalstocks $DDS

@leevalueroach 3h ago

Lee Roach on X

@dividendology Probably $RYN. Tech would be too hard as it’s ever changing. Land and timber have stood the test of time and at this valuation you are not paying a crazy premium.

@leevalueroach 3h ago

Lee Roach on X

Any rational person should lever themselves up until infinity on 0% convertible debt when rates are pushing 6%. You would be irrational to not do that. Especially if you are any good at capital allocation. How do you think $GME got $5bn of cash on the balance sheet and 10% of eBay. Oh and they made over $1bn in mark to market returns on eBay so far. And 6% on the remaining $5bn is $300 million of interest income per year. All for a zero percent convert that is still out of the money. One of the best capital allocation moves I’ve ever seen on Wall Street.

@ChrisCamillo 9h ago

Chris Camillo on X

@Pickle_Trader Anything’s possible in financial markets. An 80-90% drop in $BE is highly unlikely but i accept it as a possible outcome. Investing is a game of probabilities not certainties.

@blondesnmoney 10h ago

Cluseau Investments on X

Avis Budget has such poor service the entire company is run like a scam with bogus charges. When $CAR is finally zeroed I'll get a good laugh

@aleabitoreddit 12h ago

Serenity on X

So two things: 1. I'm now fundamentally positive on $IREN post Mirantis acquisition and after their recent earnings. Their operating outlook and ability to finance has looked more compelling. 2. That doesn't always translate to appreciating share price and ROI to shareholders. I have caution regarding their existing $6B ATM, which now has $2.37B left (so they have been going through it). As well as CEO executive compensation, which I'd argue would be more beneficial if this were done through appreciating share prices rather than dilution. Obviously optics on their NBA Warriors deals are very bad while they're unprofitable... but I'd treat this as noise relative to the scale of the ATM overhang + executive comp. So a lot of weighing different float + market dynamics vs. operational business, but I'd argue this is something that still can be addressed.

@aleabitoreddit 12h ago

Serenity on X

Even with current narratives like biotech eg. $TWST, there's 100%+ Y/Y growth from their AI testing segment with Anthropic. But if you look at company overall revenue projections, they're only calling for double revenue growth by 2031 (implying 15% annual growth). I'm sure they can beat, but this seems relatively slow compared to AI supply chains growing hundreds to 1000% Y/Y and seeing record levels of net income growth Q/Q. Not all bottlenecks have the same economic impact the way hyperscaler capex in AI supply chains does.